Chemed (CHE)
(Delayed Data from NYSE)
$584.89 USD
-1.28 (-0.22%)
Updated Sep 3, 2024 04:00 PM ET
After-Market: $585.47 +0.58 (0.10%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum B VGM
Industry / Sector Report
Industry : Medical - Outpatient and Home Healthcare
Zacks Industry Rank
Top 19% (48 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.33 | 1.68 | 9.99 |
Current Quarter Estimate | 5.76 | 0.83 | 61.00 |
Year Ago Quarter Estimate | 5.32 | -0.88 | 54.84 |
Next Quarter Estimate | 7.05 | 0.84 | 63.00 |
Next Year Estimate | 25.48 | 6.12 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 16.16 | 16.20 | 15.67 |
Next Year | 8.06 | 17.00 | 11.34 |
Last 5 Years | 14.10 | 4.20 | 8.10 |
Next 5 Years | 11.30 | 12.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 25.95 | 18.17 |
Price/Book (MRQ) | 7.31 | 2.64 |
Price/Cash Flow (MRFY) | 23.86 | 15.16 |
Dividend Yield | 0.34% | 0.00% |
Net Profit Margin (TTM) | 12.88% | 3.16% |
Return on Equity (TTM) | 29.21% | 9.81% |
Debt to Equity (MRQ) | 0.00 | 30.21 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.